Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.

@article{Balagopal2014AntiretroviralTI,
  title={Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.},
  author={Ashwin Balagopal and Abraham J. Kandathil and Yvonne Higgins and Jonathan Wood and Justin Richer and Jeffrey J. Quinn and Lois Eldred and Zhiping Li and Stuart C. Ray and Mark S Sulkowski and David L. Thomas},
  journal={Hepatology},
  year={2014},
  volume={60 2},
  pages={
          477-86
        }
}
UNLABELLED Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) cause substantial mortality, especially in persons chronically infected with both viruses. HIV infection raises plasma HCV RNA levels and diminishes the response to exogenous alpha interferon (IFN). The degree to which antiretroviral therapy (ART) control of infection overcomes these HIV effects is unknown. Participants with HIV-HCV coinfection were enrolled in a trial to measure HCV viral kinetics after IFN… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Interferon signaling and treatment outcome in chronic hepatitis C.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2008
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

Antiretroviral-induced VLDL Apolipoprotein Increases Are Associated With Change in HCV Viral Load in HIV/HCV Co-infected Individuals

S. N. Naggie, K. Patel, +8 authors C. Hicks
  • 20th Conference on Retroviruses and Opportunistic Infections
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2013
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL